ArticleLeukemia & lymphoma2022

Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience.

Samantha J Seitter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.